Clough Capital Partners’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-59,800
Closed -$3.65M 193
2015
Q1
$3.65M Sell
59,800
-13,700
-19% -$936K 0.12% 144
2014
Q4
$4.3M Sell
73,500
-233,600
-76% -$11.9M 0.15% 127
2014
Q3
$13.2M Sell
307,100
-158,400
-34% -$7.1M 0.49% 69
2014
Q2
$23.4M Buy
465,500
+335,100
+257% +$15.5M 0.74% 51
2014
Q1
$5.75M Sell
130,400
-129,700
-50% -$6.17M 0.18% 126
2013
Q4
$10.6M Buy
260,100
+12,500
+5% +$462K 0.35% 96
2013
Q3
$8.32M Buy
+247,600
New +$8.06M 0.26% 127

Other funds holding ALKS

Clough Capital Partners's ALKS Position: Q2 2015 in Review

Clough Capital Partners sold out of Alkermes (ALKS) in Q2 2015, closing a stake of 59,800 shares — an estimated $3.65M sold.

Clough Capital Partners first reported a position in ALKS in Q3 2013 and held it in 7 quarters. The position peaked at $23.4M in Q2 2014. 273 funds tracked by Wall St. Rank hold ALKS as of Q2 2015.

  • Clough Capital Partners reported no remaining Alkermes position as of Q2 2015 after selling out during the quarter.
  • Clough Capital Partners sold 59,800 Alkermes shares in Q2 2015, an estimated $3.65M.
  • Clough Capital Partners first reported a position in Alkermes in Q3 2013 and held it in 7 quarters.
  • Clough Capital Partners's Alkermes position peaked at $23.4M in Q2 2014.
  • 273 funds tracked by Wall St. Rank held Alkermes as of Q2 2015.

Based on Clough Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.